• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒感染后病毒感染后嗅觉功能障碍:大流行后预期的临床挑战。

Post Viral Olfactory Dysfunction After SARS-CoV-2 Infection: Anticipated Post-pandemic Clinical Challenge.

作者信息

Kapoor Dhruv, Verma Neha, Gupta Neelima, Goyal Arun

机构信息

Department of Otorhinolaryngology, University College of Medical Sciences, Delhi, India.

Present Address: Department of Otorhinolaryngology, Guru Teg Bahadur Hospital, Ward 25, Delhi, 110 095 India.

出版信息

Indian J Otolaryngol Head Neck Surg. 2022 Dec;74(Suppl 3):4571-4578. doi: 10.1007/s12070-021-02730-6. Epub 2021 Jul 7.

DOI:10.1007/s12070-021-02730-6
PMID:34249668
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8260324/
Abstract

Persistent olfactory dysfunction (OD) is the second most common symptom of post coronavirus disease-19 (COVID-19) now being termed long-COVID. Its prevalence after recovery from COVID-19 is estimated to be 12% after nearly 6 months of follow-up. It thus becomes imperative for the treating clinicians to update themselves with the pathophysiology of this post COVID disability as well as the tools for diagnosis and the available treatment options. A systematic literature search was performed as per PRISMA guidelines in MEDLINE, Cochrane Library, LILACS, Google Scholar, and medRxiv databases. The keywords used were , , , , , and . All articles were studied for definition, mechanism, diagnostic tests and treatment options for post COVID OD. 33 published articles and 8 ongoing trials were found relevant and included after full-text review. SARS-CoV-2 can cause conductive, neural and central OD. Olfactory evaluation can be done both subjectively (visual analogue scale) and objectively (Sniffin' sticks, Sinonasal Outcome Test, University of Pennsylvania Smell Identification Test and modified Davidson's alcohol sniff test). They can be used to detect and follow-up patients. Despite several on-going clinical trials, the most reliable and advisable treatment option available till date is olfactory training.

摘要

持续性嗅觉功能障碍(OD)是新冠病毒病(COVID-19)后第二常见的症状,现被称为“长新冠”。在从COVID-19康复后,经过近6个月的随访,其患病率估计为12%。因此,治疗临床医生必须了解这种新冠后遗症的病理生理学、诊断工具和可用的治疗选择。按照PRISMA指南在MEDLINE、Cochrane图书馆、LILACS、谷歌学术和medRxiv数据库中进行了系统的文献检索。使用的关键词有 、 、 、 、 、 和 。对所有文章进行了关于新冠后OD的定义、机制、诊断测试和治疗选择的研究。经过全文审查,发现33篇已发表文章和8项正在进行的试验相关并纳入研究。严重急性呼吸综合征冠状病毒2(SARS-CoV-2)可导致传导性、神经性和中枢性OD。嗅觉评估可以主观地(视觉模拟量表)和客观地(嗅棒、鼻窦结局测试、宾夕法尼亚大学嗅觉识别测试和改良的戴维森酒精嗅觉测试)进行。它们可用于检测和随访患者。尽管有几项正在进行的临床试验,但迄今为止最可靠、最可取的治疗选择是嗅觉训练。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4639/9895219/fc90e0c2f267/12070_2021_2730_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4639/9895219/fc90e0c2f267/12070_2021_2730_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4639/9895219/fc90e0c2f267/12070_2021_2730_Fig1_HTML.jpg

相似文献

1
Post Viral Olfactory Dysfunction After SARS-CoV-2 Infection: Anticipated Post-pandemic Clinical Challenge.新型冠状病毒感染后病毒感染后嗅觉功能障碍:大流行后预期的临床挑战。
Indian J Otolaryngol Head Neck Surg. 2022 Dec;74(Suppl 3):4571-4578. doi: 10.1007/s12070-021-02730-6. Epub 2021 Jul 7.
2
A systematic review and meta-analysis protocol examining the clinical characteristics and epidemiological features of olfactory dysfunction (OD) in coronavirus disease 2019 (COVID-19).一项系统评价和荟萃分析方案,旨在研究 2019 年冠状病毒病(COVID-19)中嗅觉功能障碍(OD)的临床特征和流行病学特征。
Syst Rev. 2021 Mar 11;10(1):73. doi: 10.1186/s13643-021-01624-6.
3
Long-lasting olfactory dysfunction in COVID-19 patients.新冠病毒感染患者的持久嗅觉功能障碍。
Eur Arch Otorhinolaryngol. 2022 Jul;279(7):3485-3492. doi: 10.1007/s00405-021-07153-1. Epub 2021 Nov 10.
4
Targeting Neuroinflammation to Alleviate Chronic Olfactory Dysfunction in Long COVID: A Role for Investigating Disease-Modifying Therapy (DMT)?针对神经炎症以减轻长新冠中的慢性嗅觉功能障碍:研究疾病修正疗法(DMT)的作用?
Life (Basel). 2023 Jan 13;13(1):226. doi: 10.3390/life13010226.
5
Recovery rates of persistent post-COVID-19 olfactory dysfunction using psychophysical assessment: A longitudinal cohort study.使用心理物理学评估的新冠后持续性嗅觉功能障碍的恢复率:一项纵向队列研究。
World J Otorhinolaryngol Head Neck Surg. 2024 May 6;10(2):79-87. doi: 10.1002/wjo2.179. eCollection 2024 Jun.
6
Treatment of post-viral olfactory dysfunction: an evidence-based review with recommendations.病毒性嗅觉功能障碍的治疗:基于证据的综述及推荐。
Int Forum Allergy Rhinol. 2020 Sep;10(9):1065-1086. doi: 10.1002/alr.22624. Epub 2020 Jun 25.
7
Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo- Controlled Clinical Trial.棕榈酸乙酯酰胺和叶黄素联合嗅觉训练治疗 COVID-19 后嗅觉障碍:一项多中心、双盲、随机安慰剂对照临床试验。
Curr Neuropharmacol. 2022;20(10):2001-2012. doi: 10.2174/1570159X20666220420113513.
8
Prevalence and 24-month recovery of olfactory dysfunction in COVID-19 patients: A multicentre prospective study.新冠病毒患者嗅觉功能障碍的流行情况和 24 个月的恢复情况:一项多中心前瞻性研究。
J Intern Med. 2023 Jan;293(1):82-90. doi: 10.1111/joim.13564. Epub 2022 Sep 1.
9
Olfactory changes after endoscopic sinus surgery for chronic rhinosinusitis: A meta-analysis.慢性鼻-鼻窦炎鼻内镜手术后嗅觉变化的Meta 分析。
Clin Otolaryngol. 2021 Jan;46(1):41-51. doi: 10.1111/coa.13639. Epub 2020 Sep 23.
10
Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.针对新冠后持续性嗅觉功能障碍的治疗干预措施。
Cochrane Database Syst Rev. 2021 Jul 22;7(7):CD013876. doi: 10.1002/14651858.CD013876.pub2.

引用本文的文献

1
Polyunsaturated Fatty Acids as Potential Treatments for COVID-19-Induced Anosmia.多不饱和脂肪酸作为新冠病毒感染所致嗅觉丧失的潜在治疗方法
Biomedicines. 2024 Sep 12;12(9):2085. doi: 10.3390/biomedicines12092085.
2
Traditional Chinese medicine for post-viral olfactory dysfunction: A systematic review.用于病毒感染后嗅觉功能障碍的中医药:一项系统评价
Integr Med Res. 2024 Jun;13(2):101045. doi: 10.1016/j.imr.2024.101045. Epub 2024 Apr 25.
3
fNIRS a novel neuroimaging tool to investigate olfaction, olfactory imagery, and crossmodal interactions: a systematic review.

本文引用的文献

1
Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study.COVID-19 非住院患者发病后 1.5-6 个月持续存在的症状:一项基于人群的队列研究。
Thorax. 2021 Apr;76(4):405-407. doi: 10.1136/thoraxjnl-2020-216377. Epub 2020 Dec 3.
2
Nasal lavage containing Angiotensin-Converting Enzyme-2 agonist can prevent and reduce viral load in COVID-19.鼻腔冲洗含有血管紧张素转换酶 2 激动剂,可预防和降低 COVID-19 病毒载量。
Med Hypotheses. 2020 Nov;144:110207. doi: 10.1016/j.mehy.2020.110207. Epub 2020 Aug 24.
3
Understanding COVID-19-Related Olfactory Dysfunction.
功能近红外光谱成像技术:一种用于研究嗅觉、嗅觉意象及跨模态交互作用的新型神经成像工具——系统综述
Front Neurosci. 2024 Jan 31;18:1266664. doi: 10.3389/fnins.2024.1266664. eCollection 2024.
4
Olfactory immunology: the missing piece in airway and CNS defence.嗅觉免疫学:气道和中枢神经系统防御中的缺失环节。
Nat Rev Immunol. 2024 Jun;24(6):381-398. doi: 10.1038/s41577-023-00972-9. Epub 2023 Dec 14.
5
Oral SARS-CoV-2 Inoculation Causes Nasal Viral Infection Leading to Olfactory Bulb Infection: An Experimental Study.经口接种 SARS-CoV-2 可导致鼻腔病毒感染进而引起嗅球感染:一项实验研究。
Front Cell Infect Microbiol. 2022 Jun 13;12:924725. doi: 10.3389/fcimb.2022.924725. eCollection 2022.
JAMA Otolaryngol Head Neck Surg. 2021 Jan 1;147(1):109. doi: 10.1001/jamaoto.2020.4269.
4
Olfactory Bulb MRI and Paranasal Sinus CT Findings in Persistent COVID-19 Anosmia.持续性 COVID-19 嗅觉丧失患者的嗅球 MRI 和鼻窦 CT 表现。
Acad Radiol. 2021 Jan;28(1):28-35. doi: 10.1016/j.acra.2020.10.006. Epub 2020 Oct 19.
5
Neuropilin-1 is a host factor for SARS-CoV-2 infection.神经纤毛蛋白 1 是 SARS-CoV-2 感染的宿主因子。
Science. 2020 Nov 13;370(6518):861-865. doi: 10.1126/science.abd3072. Epub 2020 Oct 20.
6
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.神经纤毛蛋白-1 促进 SARS-CoV-2 细胞进入和感染性。
Science. 2020 Nov 13;370(6518):856-860. doi: 10.1126/science.abd2985. Epub 2020 Oct 20.
7
Neuropilin‑1 as a new potential SARS‑CoV‑2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID‑19.神经纤毛蛋白 1 作为新型潜在的 SARS-CoV-2 感染介质,与 COVID-19 的神经特征和中枢神经系统受累相关。
Mol Med Rep. 2020 Nov;22(5):4221-4226. doi: 10.3892/mmr.2020.11510. Epub 2020 Sep 15.
8
Olfactory and gustatory dysfunction in COVID-19 patients: A meta-analysis study.新冠肺炎患者的嗅觉和味觉功能障碍:一项荟萃分析研究。
Physiol Rep. 2020 Sep;8(18):e14578. doi: 10.14814/phy2.14578.
9
Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia.SARS-CoV-2 进入基因在嗅觉系统中的非神经元表达提示了 COVID-19 相关嗅觉丧失的潜在机制。
Sci Adv. 2020 Jul 31;6(31). doi: 10.1126/sciadv.abc5801. Epub 2020 Jul 24.
10
Loss of smell in patients with COVID-19: MRI data reveal a transient edema of the olfactory clefts.COVID-19 患者嗅觉丧失:MRI 数据显示嗅裂短暂性水肿。
Neurology. 2020 Dec 8;95(23):e3145-e3152. doi: 10.1212/WNL.0000000000010806. Epub 2020 Sep 11.